The SLC25A19 gene helps move the active form of vitamin B1 into mitochondria, the parts of cells that make energy. This is especially important for the brain and nerves, which need a steady energy supply to work well. If both copies of the gene do not work properly, the body may struggle to use vitamin B1 inside cells, leading to severe developmental and neurologic problems such as small head size, weakness, movement changes, or episodes of brain dysfunction.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are used mainly to control when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SLC25A19Gene function
What if the gene works
The SLC25A19 gene helps move active vitamin B1 into mitochondria, the parts of cells that make energy. This supports energy production and helps tissues with high energy needs, like the brain and muscles, work normally.
Risk
What if the gene does not work
SLC25A19 gene variants can disrupt mitochondrial vitamin B1 transport and cause brain conditions ranging from severe early developmental problems with small head size to childhood episodes of weakness or abnormal movements. Milder variants may cause later onset or fewer features.
Treatment
What does that mean for your treatment
No SLC25A19-specific treatment or management approach is currently established in clinical guidelines. Because the SLC25A19 gene is linked to handling thiamine inside cells, thiamine-based treatment has been explored in case reports and small studies, but benefit appears variable and is not yet guideline-based.
Conditions associated with SLC25A19
Gene function
What if the gene works
Your cells need the active form of vitamin B1 to turn food into usable energy. The SLC25A19 gene helps move this vitamin form, called thiamine pyrophosphate, into mitochondria, the parts of cells that make most energy. This transport is a core part of SLC25A19 gene function in the body and supports routine energy use in tissues such as the brain and muscles.
The SLC25A19 gene makes a carrier that moves thiamine pyrophosphate (the active form of vitamin B1) into mitochondria. This gives the cell’s energy machinery access to a key helper molecule.
Inside mitochondria, this vitamin helper supports enzymes that break down fuel from food. That process helps cells make ATP, the main form of usable energy.
The SLC25A19 gene supports the handling of carbohydrates and some amino acids by supplying thiamine pyrophosphate to mitochondrial enzymes. This helps energy production stay steady during everyday cell activity.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and help shape normal human diversity, including variations in appearance, metabolism, and the way the body reacts to environmental influences. Many do not produce any noticeable effect and simply represent natural genetic variation. At times, though, a variant changes gene function more markedly and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC25A19 gene can weaken or disrupt the carrier that moves the active form of vitamin B1 into mitochondria, the parts of cells that make energy. Some SLC25A19 gene variants mainly reduce transport efficiency, while more severe variants can destabilize the protein or greatly limit its activity. This leaves several mitochondrial enzymes with less of the helper molecule they need. In people with more disruptive variants, the linked condition often starts earlier and may be more severe.
How variants are linked to conditions
Pathogenic variants in the SLC25A19 gene cause rare inherited conditions, including Amish congenital microcephaly and thiamine metabolism dysfunction syndrome 4. These conditions can involve poor brain growth before birth, a very small head size, developmental delay, seizures, movement problems, and episodes of sudden neurologic decline. In the medical literature, SLC25A19 gene variants linked to conditions are uncommon but well established.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence that specific lifestyle or environmental factors increase or reduce health risks related to the SLC25A19 gene. For people with disease-causing changes in both copies of SLC25A19, risk is mainly shaped by the inherited gene changes rather than day-to-day habits.
Inheritance of SLC25A19 variants
Variants in the SLC25A19 gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two nonworking copies, one from each parent, to have an SLC25A19-related condition. Parents who each carry one variant are typically unaffected, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This is the usual pattern described for how SLC25A19 gene variants are inherited.
What does my SLC25A19 result mean for my family?
For families with a disease-causing SLC25A19 result, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other close relatives could carry the same change without knowing it. Family planning questions sometimes come up because two carriers can have another affected child together.
Genetic information
Genetic testing
How you find out about variants
SLC25A19 genetic testing usually uses a blood or saliva sample to read the SLC25A19 gene and look for variants. This may be done as single gene testing or as part of a larger panel or exome test when symptoms suggest a related inherited condition. Results can show whether you carry one or two relevant variants and whether family members may be carriers.
When should I consider getting a genetic test?
Genetic testing for the SLC25A19 gene may be considered if a baby or child has severe early brain and nerve symptoms, such as very small head size, seizures, movement problems, or repeated episodes of sudden weakness or confusion. It can also be helpful when these problems run in the family or when a relative already has an SLC25A19 genetic change.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but how much they explain varies by the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make personal experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may absorb, break down, transport, or respond to a drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects. Medication response also depends on other factors, including age, kidney and liver function, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences shape the way people respond to medications. It examines connections between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes affect both how strongly a drug works and how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the SLC25A19 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so any questions about medicines, side effects, or new symptoms are best discussed with your doctor.